Search clinical trials for: individualized mRNA neoantigen vaccine (mRNA-0523-L001)
Total 192 results
-
Shanghai Jiao Tong University School of MedicineRecruitingMedullary Thyroid Cancer | Pancreatic Neuroendocrine Tumor | Adrenal Cortical Carcinoma | Thymic Neuroendocrine CarcinomaChina
-
Second Affiliated Hospital of Guangzhou Medical...Not yet recruitingSolid Tumor, Adult
-
Stemirna TherapeuticsPeking University Cancer Hospital & InstituteNot yet recruitingAdvanced Malignant Solid Tumors
-
YueJuan ChengNeoCuraRecruiting
-
Tan Tock Seng HospitalKK Women's and Children's Hospital; Duke-NUS Graduate Medical School; A*StarRecruiting
-
University of FloridaUniversity of California, San Francisco; Florida Department of Health; Pacific... and other collaboratorsRecruiting
-
CureVacActive, not recruitingGlioblastomaBelgium, Germany, Netherlands
-
ModernaTX, Inc.Active, not recruitingSeasonal InfluenzaUnited States
-
Sheba Medical CenterModernaTX, Inc.CompletedCOVID-19 | SARS CoV 2 Infection | COVID-19 Pandemic | ImmunogenicityIsrael
-
Sun Yat-sen UniversityTianjin Hengjia Biotechnology Development co., LTDRecruitingNon Small Cell Lung CancerChina
-
GlaxoSmithKlineActive, not recruiting
-
Shanghai Zhongshan HospitalNot yet recruitingPosto Perative Hepatocellular Carcinoma
-
National Institute of Allergy and Infectious Diseases...PPDCompleted
-
Stemirna TherapeuticsRecruitingSolid TumorAustralia, Austria
-
jianming xuNeoCuraRecruitingGastric Cancer | Esophageal Cancer | Liver CancerChina
-
SeqirusActive, not recruiting
-
ModernaTX, Inc.CompletedSeasonal InfluenzaUnited States
-
Karolinska University HospitalKarolinska InstitutetActive, not recruiting
-
International AIDS Vaccine InitiativeEmory University; Fred Hutchinson Cancer Center; George Washington University; ModernaTX... and other collaboratorsActive, not recruiting
-
ModernaTX, Inc.Active, not recruitingA Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy AdultsInfluenza | SARS-CoV-2United States
-
Methodist Health SystemCompletedCOVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster DoseCOVID-19 | COVID-19 PneumoniaUnited States
-
Duke UniversityWashington University School of Medicine; University of Pittsburgh; Centers for... and other collaboratorsCompletedCOVID-19 | InfluenzaUnited States
-
Sanofi Pasteur, a Sanofi CompanyTerminatedCOVID-19United States, Australia, Brazil, Honduras
-
University of FloridaSuspended
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | COVID-19 InfectionUnited States
-
CureVacCompleted
-
Sunnybrook Health Sciences CentreUniversity Health Network, Toronto; Unity Health Toronto; Scarborough General... and other collaboratorsTerminatedCOVID-19 | Chronic Kidney DiseasesCanada
-
ANRS, Emerging Infectious DiseasesLinKinVax; Vaccine Research Institute (VRI), FranceRecruiting
-
AIM Vaccine Co., Ltd.Ningbo Rongan Biological Pharmaceutical Co. Ltd.; LiveRNA Therapeutics Inc.Not yet recruiting
-
University of LiegePfizerRecruitingCoronavirus Disease 2019 (Covid19) | Hematopoietic NeoplasmsBelgium
-
CNBG-Virogin Biotech (Shanghai) Ltd.Shulan (Hangzhou) HospitalRecruitingSARS-CoV-2 InfectionChina
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
The University of Hong KongActive, not recruiting
-
AIM Vaccine Co., Ltd.First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...Active, not recruiting
-
Mayo ClinicTerminatedOsteoarthritis | Systemic Lupus Erythematosus | Psoriatic Arthritis | Sjogren's Syndrome | Gout | Ankylosing Spondylitis | Inflammatory Myositis | Arthritis of Multiple Sites Associated With Inflammatory Bowel Disease (Diagnosis)United States
-
National Institute of Allergy and Infectious Diseases...CompletedCovid19 | SARS-CoV2 InfectionUnited States
-
Sanofi Pasteur, a Sanofi CompanyRecruitingInfluenza ImmunizationUnited States, Puerto Rico
-
Chulalongkorn UniversityBioNet-Asia; Chula Clinical Research Center (Chula CRC), Faculty of Medicine... and other collaboratorsRecruitingSafety of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Tolerability of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Immune Response of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Safety of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | Immune Response... and other conditionsThailand
-
Changhai HospitalStemirna TherapeuticsUnknownPancreatic Adenocarcinoma | Gastric Adenocarcinoma | Colorectal Adenocarcinoma | Advanced Esophageal Squamous CarcinomaChina
-
West China HospitalRecruitingHepatocellular Carcinoma | Liver CancerChina
-
West China HospitalRecruiting
-
Stemirna TherapeuticsThe First Affiliated Hospital of Zhengzhou UniversityRecruitingEsophageal Cancer | Non Small Cell Lung CancerChina
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedCOVID-19 | Vaccine Adverse Reaction | Vaccine Reaction | Liver Transplant; Complications | Lung Transplant; Complications | Vaccine Response Impaired | VaccinationItaly
-
Stemirna TherapeuticsCompletedCOVID-19 PandemicLao People's Democratic Republic
-
Yu QinEnrolling by invitationCorona Virus Disease 2019(COVID-19)China
-
Centre Hospitalier Universitaire de Saint EtienneSanofi Pasteur, a Sanofi Company; Bioster, a.s.Completed
-
GlaxoSmithKlineRecruitingRespiratory Syncytial Virus InfectionsUnited States, Belgium, Netherlands, Spain
-
ModernaTX, Inc.Active, not recruitingInfluenza | SARS-CoV-2United States
-
Korea University Guro HospitalKorea University Anam Hospital; Ajou University School of Medicine; Korean Center... and other collaboratorsRecruitingCOVID-19 | Vaccine Adverse Reaction | Vaccine Immune ResponseKorea, Republic of
-
Ente Ospedaliero Ospedali GallieraUniversity of GenoaRecruitingNeoplasms | Cancer, Treatment-RelatedItaly